Sphingolipid metabolism enzymes (SME)

Sphingolipid metabolism enzymes represent a diverse group of proteins responsible for the synthesis, interconversion, and degradation of sphingolipids, which are essential components of eukaryotic cell membranes and potent signaling molecules. Key enzymes in this pathway include serine palmitoyltransferase, ceramide synthase, sphingomyelinase, and sphingosine kinase, which collectively regulate the balance between pro-apoptotic lipids like ceramide and pro-survival lipids like sphingosine-1-phosphate (S1P). Dysregulation of these enzymes is linked to numerous pathologies, including cancer, where elevated S1P promotes tumor growth, and lysosomal storage diseases like Gaucher and Niemann-Pick, caused by specific enzymatic deficiencies. Pharmacological targeting of these enzymes involves inhibitors to reduce toxic lipid accumulation or enzyme replacement therapies to restore metabolic function. Because this term refers to a broad class of enzymes rather than a single protein, it is often considered a pathway-level target in drug discovery and metabolic research.

Other names

Sphingolipid metabolic pathway enzymesSphingolipid-modifying enzymesEnzymes of sphingolipid metabolism

Inhibition of specific enzymes (e.g., Sphingosine kinase, Glucosylceramide synthase) or replacement of deficient enzymes (e.g., Acid sphingomyelinase) to modulate levels of bioactive sphingolipids like ceramide and sphingosine-1-phosphate.